Altintas Dogan et al 75 experiment found that liraglutide significantly reduced body weight, decreased inflammatory markers such as IL-6 and MCP-1, increased exertional spirometry (FVC) and carbon monoxide diffusion capacity, and improved COPD assessment test scores, but no significant improvement in FEV1, FEV1/FVC, or 6-minute walk tests, suggesting the possibility that GLP-1RA may reduce inflammatory responses, improve lung function, and mitigate the degree of impaired health in patients with COPD
While tirzepatide does increase metabolism through its own mechanisms, dramatic or unexpected weight loss should prompt a thyroid function check
Retrieved 31 October 2023
It's unique to retatrutide because no other approved obesity medication activates glucagon receptors
Clinical trials show gastrointestinal effects are among the most frequently reported side effects, with diarrhoea and constipation both classified as common
Comparing GLP-1 vs Wegovy When comparing glp-1 vs wegovy , its important to look at effectiveness, dosage, and usage
.png)
